|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/46 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 9/12 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 2606891 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12196725.1 |
| Date of filing the European patent application | 2012-12-12 | |
| (97) | Date of publication of the European application | 2013-06-26 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-05 |
| (46) | Date of publication of the claims translation | 2015-03-25 |
| (30) | Number | Date | Country code |
| 201161577315 P | 2011-12-19 | US | |
| 201200525 | 2012-01-13 | GB |
| (72) |
Zeng, Xian-Ming, US
|
| (73) |
Teva Branded Pharmaceutical Products R&D, Inc.,
41 Moores Road, Frazer PA 19355,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Inhaliuojamas vaistas, apimantis tiotropiumą |
| An inhalable medicament comprising tiotropium |
| Payment date | Validity (years) | Amount | |
| 2021-11-24 | 10 | 231.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2021-12-06 |